RA Capital Management’s Myovant Sciences Ltd. MYOV Stock Holding History

RA Capital Management’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-6,166,875	Closed	-$32.1M	–	39
2019 Q3	$32.1M	Sell	6,166,875 -378,767	-6%	-$2.81M	1.91%	16
2019 Q2	$59.2M	Buy	6,545,642 +3,001,415	+85%	+$44.8M	3.18%	9
2019 Q1	$84.6M	Sell	3,544,227 -167,322	-5%	-$3.42M	3.65%	9
2018 Q4	$60.9M	Buy	3,711,549 +259,690	+8%	+$5.12M	3.55%	9
2018 Q3	$91.6M	Buy	3,451,859 +621,404	+22%	+$14.1M	4.9%	6
2018 Q2	$64.7M	Hold	2,830,455	–	–	4.2%	7
2018 Q1	$60.2M	Hold	2,830,455	–	–	4.61%	4
2017 Q4	$35.8M	Hold	2,830,455	–	–	2.99%	10
2017 Q3	$43.8M	Buy	2,830,455 +22,905	+0.8%	+$279K	3.96%	9
2017 Q2	$32.8M	Buy	2,807,550 +459,128	+20%	+$5.69M	3.77%	9
2017 Q1	$27.6M	Buy	2,348,422 +848,422	+57%	+$9.73M	3.38%	8
2016 Q4	$18.7M	Buy	+1,500,000	New	+$17.4M	2.64%	11

Other funds holding MYOV

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NCM

NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RA Capital Management's MYOV Position: Q4 2019 in Review

RA Capital Management sold out of Myovant Sciences Ltd. (MYOV) in Q4 2019, closing a stake of 6,166,875 shares — an estimated $32.1M sold.

RA Capital Management first reported a position in MYOV in Q4 2016 and held it in 12 quarters. The position peaked at $91.6M in Q3 2018. 77 funds tracked by Wall St. Rank hold MYOV as of Q4 2019.

RA Capital Management reported no remaining Myovant Sciences Ltd. position as of Q4 2019 after selling out during the quarter.
RA Capital Management sold 6,166,875 Myovant Sciences Ltd. shares in Q4 2019, an estimated $32.1M.
RA Capital Management first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 12 quarters.
RA Capital Management's Myovant Sciences Ltd. position peaked at $91.6M in Q3 2018.
77 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2019.

Based on RA Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.